XML 1092 R34.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Share - Based Compensation (Tables)
12 Months Ended
Jun. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of the performance shares and restricted stock activity
                 
            Weighted-Average  
  June 30, 2011         Grant-Date  
  (Share amounts in thousands)   Shares     Fair Value  
 
  Nonvested, beginning of year
    156     $ 20.67  
  Granted
    66       29.27  
  Vested
               
 
  Nonvested, end of year
    222     $ 23.23  
 
                 
            Weighted-Average  
June 30, 2011           Grant-Date  
(Share amounts in thousands)   Shares     Fair Value  
 
Nonvested, beginning of year
    104     $ 21.41  
Granted
    85       30.31  
Vested
    (27 )     22.13  
 
Nonvested, end of year
    162     $ 25.97  
 
Schedule of share based compensation expense
                         
Year Ended June 30,   2011     2010     2009  
 
SARs and options
  $ 2,473     $ 3,020     $ 3,702  
Performance shares
    1,705       1,076          
Restricted stock and RSUs
    1,453       1,029       392  
 
Total compensation costs under award programs
  $ 5,631     $ 5,125     $ 4,094  
 
Weighted-average assumptions used for SARs and stock option grants issued
                         
    2011     2010     2009  
 
Expected life, in years
    5.1       5.5       5.5  
Risk free interest rate
    1.6 %     2.4 %     2.9 %
Dividend yield
    2.5 %     2.5 %     2.2 %
Volatility
    46.2 %     52.2 %     48.4 %
Per share fair value of SARs and stock options granted during the year
  $ 9.78     $ 8.45     $ 10.31  
 
Summary of SARs and stock option activity
                 
  June 30, 2011           Weighted-Average  
  (Share amounts in thousands)   Shares     Exercise Price  
 
  Outstanding, beginning of year     2,400     $ 18.19  
  Granted     227       29.60  
  Exercised     (822 )     11.50  
  Forfeited     (1 )     20.99  
 
  Outstanding, end of year     1,804     $ 22.68  
 
  Exercisable at end of year     1,169     $ 21.03